Lyfius Pharma Private Limited, a fully owned step-down subsidiary of Aurobindo Pharma, has announced the resumption of production at its Penicillin-G manufacturing facility in Kakinada, Andhra Pradesh
Cadila Pharmaceuticals has launched Bilacad Dex Syrup, a fixed-dose combination for meeting the mounting burden of respiratory and allergic conditions.
.jpeg "Telangana CM Announces Rs 1 Cr Relief After Pharma Plant Blast")
In an unprecedented decision following the devastating explosion at Sigachi Industries' pharma facility in Sangareddy, has stated that he will be awarding Rs 1 crore for every deceased worker's family. The explosion actually...
Jiangsu Recbio Technology Company Limited (02179.HK) signed a licensing cooperation agreement with Biological E. Limited (BE), the Indian vaccine and pharmaceuticals industry leader
Biocon Ltd is seeking regulatory approval for its generic version of Ozempic (semaglutide) to get into Canada's high growth obesity drug market, aiming for a submission date of September 2025. This would allow for a...
In a strategic shift to develop its position in India’s growing self-care and over-the-counter (OTC) market, Lupin Limited has formally separated its consumer healthcare division and formed a wholly owned subsidiary called LupinLife Consumer...
In one of India’s deadliest industrial disasters in recent years, the death toll from the massive explosion at Sigachi Industries’ pharmaceutical manufacturing unit in Telangana has risen to 36. The blast occurred in the spray-dryer section of...
Welcure Drugs & Pharmaceuticals announced two significant export sourcing orders worth ?85.6 crore, signaling yet another step toward global pharmaceutical sourcing solutions. The dual sets of contracts were from Thailand-based clients...
With nearly $2 billion in yearly revenues, which is already a record for India's fragmented drug-retailing industry, Apollo Hospitals Enterprises (AHEL), the largest listed healthcare chain in the nation, and its subsidiary Apollo HealthCo
Indian generic drug firms are reconsidering their US export strategy after US President Donald Trump issued an executive order (EO) to cut prescription drug prices.
, CDSCO.jpg "Fostering a Quality Culture in the Pharmaceutical Industry")